SAN ANTONIO, Dec. 10 /PRNewswire-USNewswire/ -- For the past 30 years, the San Antonio Breast Cancer Symposium has been a forum of interaction and exchange among scientists and clinicians from around the world, for breast cancer research. It is an educational milieu providing an ideal format for scientists to present, for the first time, new and late breaking data, as well as other pertinent information, including diagnostic developments.
The symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease. The scientific program consists of invited lectures and mini-symposia by experts in clinical and basic research; selected slide and poster presentations chosen from submitted abstracts; and case discussions. General sessions are 2-3 hours in duration and are the vehicle for slide presentations, each of which is allotted 10 minutes, followed by 5 minutes of discussion. Each poster session lasts 2 hours.
Approximately 8300 registrants are expected at this year's symposium; the majority of whom are physicians and researchers from more than 80 countries, (including the US and Canada), with smaller representation by affiliated health care professionals.
For all that has been discovered since we started this meeting 30 years ago, much remains to be done. We are still only beginning to unlock the secrets of breast cancer biology that we expect will lead to more effective individualized treatments. Ongoing developments in existing therapies continue to refine our ability to discover very early-stage disease and to whittle away at breast cancer-related mortality. This year at the San Antonio Breast Cancer Symposium, 5 renowned experts will present reviews and updates about multidisciplinary breast cancer treatment; the exciting area of insulin regulation and its role in breast cancer development; and the important but frequently overlooked field of symptom management. Four mini-symposia will provide expert discussion on breast cancer stem cells; developments from the Women's Health Initiative; molecular imaging; and a systems biology approach to studying the HER network. This year, there will be over 700 poster presentations highlighting new research that may lead to the critical developments of the future.
The San Antonio Breast Cancer Symposium is a collaborative effort of the San Antonio Cancer Institute and Baylor College of Medicine. The San Antonio Cancer Institute, an NCI-designated clinical cancer center, is a partnership of the Cancer Therapy and Research Center and The University of Texas Health Science Center at San Antonio.
|SOURCE San Antonio Breast Cancer Symposium|
Copyright©2007 PR Newswire.
All rights reserved